Mary Miller

Insider Reports History

Location
C/O Butterfly Network, Inc., 530 Old Whitfield Street, Guilford, CT
Signature
/s/ Adam D. Levy, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mary Miller:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Butterfly Network, Inc. General Counsel & Corp Sec Common Stock 139K $750K $5.39 Feb 16, 2022 Direct
Butterfly Network, Inc. General Counsel & Corp Sec Class A Common Stock 384K $391K $1.02 Mar 22, 2022 Direct
Acrivon Therapeutics, Inc. Chief Legal Officer Common Stock 34.6K $77.4K $2.24 Nov 14, 2025 Direct
Acrivon Therapeutics, Inc. Chief Legal Officer Stock Option (Right to Buy) 15.6K Apr 1, 2025 Direct

Insider Reports Filed by Mary Miller

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRV Acrivon Therapeutics, Inc. Nov 14, 2025 1 -$412 4 Nov 18, 2025 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Oct 17, 2025 1 -$1.01K 4 Oct 21, 2025 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Oct 1, 2025 1 -$514 4 Oct 3, 2025 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Aug 14, 2025 1 -$256 4 Aug 18, 2025 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Jul 17, 2025 1 -$737 4 Jul 21, 2025 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. May 14, 2025 1 -$210 4 May 16, 2025 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Apr 17, 2025 1 -$1.01K 4 Apr 18, 2025 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Apr 1, 2025 1 $0 4 Apr 3, 2025 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Mar 1, 2025 1 $0 4 Mar 4, 2025 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Feb 14, 2025 1 -$1.18K 4 Feb 19, 2025 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Jan 17, 2025 1 -$3.81K 4 Jan 22, 2025 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Nov 14, 2024 1 -$1.46K 4 Nov 18, 2024 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Oct 17, 2024 1 -$4.39K 4 Oct 21, 2024 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Oct 1, 2024 1 -$1.98K 4 Oct 3, 2024 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Aug 14, 2024 1 -$1.29K 4 Aug 16, 2024 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Jul 17, 2024 1 -$4.29K 4 Jul 19, 2024 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. May 14, 2024 1 -$1.54K 4 May 16, 2024 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Apr 17, 2024 1 -$5.77K 4 Apr 19, 2024 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Mar 1, 2024 1 $0 4 Nov 27, 2024 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Feb 14, 2024 1 -$738 4 Feb 16, 2024 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Jan 17, 2024 1 -$2.84K 4 Jan 19, 2024 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Nov 14, 2023 1 -$3.73K 4 Nov 16, 2023 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Oct 17, 2023 1 -$12.2K 4 Oct 19, 2023 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Sep 26, 2023 2 $0 4 Sep 28, 2023 Chief Legal Officer
ACRV Acrivon Therapeutics, Inc. Sep 26, 2023 0 $0 3 Sep 28, 2023 Chief Legal Officer
BFLY Butterfly Network, Inc. Mar 22, 2022 1 $0 4 Mar 24, 2022 General Counsel & Corp Sec
BFLY Butterfly Network, Inc. Mar 4, 2022 1 $0 4 Mar 8, 2022 General Counsel & Corp Sec
BFLY Butterfly Network, Inc. Feb 16, 2022 1 -$99.3K 4 Feb 17, 2022 General Counsel & Corp Sec